11/11 CTI BioPharma Corp. – Settlement Notice
To: All persons and/or entities who purchased or otherwise acquired any shares of the common stock of CTI BioPharma Corp. [CTIC] during the period from March 9, 2015 to February 9, 2016 and were damaged thereby; a settlement has been announced in the securities litigation known as In re CTI BioPharma Corp. Securities Litigation, 2:16-cv-00216-RSL, filed in the United States District Court for the Western District of Washington. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. […]